Dorgan; Colin Richard
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dorgan; Colin Richard.The latest application filed is for "antibacterial compounds".
- Dorgan; Colin Richard - Abingdon GB
- Dorgan; Colin Richard - Abingdon Oxfordshire GB
- Dorgan; Colin Richard - Oxfordshire N/A GB
- DORGAN; COLIN RICHARD - Oxford GB
- Dorgan; Colin Richard - Oxon GB
| Patent | Date |
|---|---|
| Antibacterial compounds Grant 9,763,925 - Wilson , et al. September 19, 2 | 2017-09-19 |
| Antibacterial Compounds App 20160184283 - WILSON; Francis Xavier ; et al. | 2016-06-30 |
| Compounds For The Treatment Of Clostridium Difficile Associated Disease App 20160145266 - Johnson; Peter David ; et al. | 2016-05-26 |
| Antibacterial compounds Grant 9,314,456 - Wilson , et al. April 19, 2 | 2016-04-19 |
| Compounds for the treatment of Clostridium difficile associated disease Grant 9,278,091 - Johnson , et al. March 8, 2 | 2016-03-08 |
| Compounds For The Treatment Of Clostridium Difficile Associated Disease App 20150209340 - Johnson; Peter David ; et al. | 2015-07-30 |
| Antibacterial Compounds App 20150150861 - WILSON; Francis Xavier ; et al. | 2015-06-04 |
| Compounds for the treatment of Clostridium difficile-associated disease Grant 8,987,308 - Johnson , et al. March 24, 2 | 2015-03-24 |
| Antibacterial compounds Grant 8,975,416 - Davis , et al. March 10, 2 | 2015-03-10 |
| Pyrrolidine Derivatives As Selective Glycosidase Inhibitors And Uses Thereof App 20140073801 - Storer; Richard ; et al. | 2014-03-13 |
| Treatment Of Duchenne Muscular Dystrophy App 20140018320 - WYNNE; GRAHAM MICHAEL ; et al. | 2014-01-16 |
| Drug Combinations For The Treatment Of Duchenne Muscular Dystrophy App 20140011782 - WYNNE; Graham Michael ; et al. | 2014-01-09 |
| Compounds For The Treatment Of Clostridium Difficile-associated Disease App 20130309191 - Johnson; Peter David ; et al. | 2013-11-21 |
| Treatment of Duchenne muscular dystrophy Grant 8,518,980 - Wynne , et al. August 27, 2 | 2013-08-27 |
| Drug combinations for the treatment of duchenne muscular dystrophy Grant 8,501,713 - Wynne , et al. August 6, 2 | 2013-08-06 |
| Compounds For The Treatment Of Clostridium Difficile-associated Disease App 20130095057 - Johnson; Peter David ; et al. | 2013-04-18 |
| Compounds having CRTH2 antagonist activity Grant 8,268,878 - Armer , et al. September 18, 2 | 2012-09-18 |
| Compounds having CRTH2 antagonist activity Grant 8,168,673 - Armer , et al. May 1, 2 | 2012-05-01 |
| Antibacterial Compounds App 20120020950 - Davis; Paul James ; et al. | 2012-01-26 |
| Compounds Having CRTH2 Antagonist Activity App 20110268693 - ARMER; Richard Edward ; et al. | 2011-11-03 |
| Treatment Of Lysosomal Storage Disorders And Other Proteostatic Diseases App 20110237538 - De Moor; Olivier ; et al. | 2011-09-29 |
| Compounds having CRTH2 antagonist activity Grant 7,999,119 - Armer , et al. August 16, 2 | 2011-08-16 |
| Drug Combinations for the Treatment of Duchenne Muscular Dystrophy App 20110195932 - Wynne; Graham Michael ; et al. | 2011-08-11 |
| Compounds For The Treatment Of Flaviviral Infections App 20110195929 - De Moor; Olivier ; et al. | 2011-08-11 |
| Drug Combinations for the Treatment of Duchenne Muscular Dystrophy App 20100168072 - Wynne; Graham Michael ; et al. | 2010-07-01 |
| Treatment Of Duchenne Muscular Dystrophy App 20100048660 - Wynne; Graham Michael ; et al. | 2010-02-25 |
| Compounds Having CRTH2 Antagonist Activity App 20100035956 - Armer; Richard Edward ; et al. | 2010-02-11 |
| Compounds Having CRTH2 Antagonist Activity App 20090192195 - Armer; Richard Edward ; et al. | 2009-07-30 |
| Treatment Of Duchenne Muscular Dystrophy App 20090075938 - Wynne; Graham Michael ; et al. | 2009-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 